Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
probucol - therapeutic use (606) 606
humans (526) 526
science & technology (404) 404
life sciences & biomedicine (392) 392
male (386) 386
animals (281) 281
probucol (281) 281
female (269) 269
biological and medical sciences (223) 223
medical sciences (218) 218
middle aged (214) 214
probucol - pharmacology (184) 184
anticholesteremic agents - therapeutic use (183) 183
cholesterol - blood (153) 153
adult (150) 150
pharmacology. drug treatments (146) 146
antioxidants - therapeutic use (134) 134
cardiovascular system & cardiology (133) 133
hypercholesterolemia - drug therapy (130) 130
aged (124) 124
phenols - therapeutic use (121) 121
abridged index medicus (116) 116
cardiac & cardiovascular systems (107) 107
rats (99) 99
antioxidants (98) 98
pharmacology & pharmacy (97) 97
general and cellular metabolism. vitamins (96) 96
triglycerides - blood (93) 93
atherosclerosis (92) 92
hyperlipidemias - drug therapy (80) 80
probucol - administration & dosage (80) 80
clinical trials as topic (75) 75
drug therapy, combination (74) 74
mice (73) 73
hyperlipoproteinemia type ii - drug therapy (72) 72
rabbits (67) 67
antioxidants - pharmacology (66) 66
peripheral vascular disease (66) 66
time factors (64) 64
lipids - blood (63) 63
lipoproteins, ldl - blood (62) 62
cholesterol, hdl - blood (59) 59
cholestyramine resin - therapeutic use (59) 59
oxidative stress (58) 58
probucol - adverse effects (57) 57
hypolipidemic agents - therapeutic use (56) 56
lipoproteins - blood (56) 56
arteriosclerosis - drug therapy (53) 53
treatment outcome (53) 53
cholesterol, ldl - blood (51) 51
probucol - analogs & derivatives (51) 51
anticholesteremic agents - pharmacology (48) 48
hypercholesterolemia - blood (47) 47
arteriosclerosis - prevention & control (44) 44
cholesterol (43) 43
disease models, animal (43) 43
lipids (42) 42
clofibrate - therapeutic use (40) 40
double-blind method (40) 40
coronary disease - prevention & control (39) 39
niacin - therapeutic use (39) 39
hyperlipoproteinemia type ii - blood (38) 38
lipoproteins, ldl - metabolism (37) 37
oxidative stress - drug effects (37) 37
rats, sprague-dawley (37) 37
arteriosclerosis - etiology (36) 36
lipoproteins, hdl - blood (35) 35
risk factors (34) 34
colestipol - therapeutic use (33) 33
medicine, research & experimental (33) 33
probucol - chemistry (33) 33
research & experimental medicine (33) 33
biochemistry & molecular biology (32) 32
drug therapy (32) 32
endocrinology & metabolism (32) 32
lipid peroxidation - drug effects (32) 32
follow-up studies (31) 31
cardiology. vascular system (30) 30
cholesterol - metabolism (30) 30
inflammation (30) 30
lovastatin - therapeutic use (29) 29
arteriosclerosis - pathology (28) 28
medicine & public health (28) 28
prospective studies (28) 28
vitamin e - therapeutic use (28) 28
hyperlipidemias - blood (27) 27
oxidation-reduction (27) 27
diabetes (26) 26
phenols - pharmacology (26) 26
cell biology (25) 25
general & internal medicine (25) 25
mice, inbred c57bl (25) 25
physiological aspects (25) 25
probucol - pharmacokinetics (25) 25
anticholesteremic agents - administration & dosage (24) 24
dose-response relationship, drug (24) 24
health aspects (24) 24
hypercholesterolemia - complications (24) 24
medicine, general & internal (24) 24
diet (23) 23
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (682) 682
Japanese (35) 35
Russian (20) 20
French (13) 13
Portuguese (13) 13
Chinese (11) 11
Spanish (7) 7
Polish (6) 6
Italian (4) 4
German (3) 3
Bulgarian (2) 2
Czech (2) 2
Norwegian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Review article: drug therapy for non‐alcoholic fatty liver disease
by COMAR, K. M and STERLING, R. K
Alimentary pharmacology & therapeutics, ISSN 0269-2813, 01/2006, Volume 23, Issue 2, pp. 207 - 215
Gastroenterology & Hepatology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Digestive system | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Other diseases. Semiology | Betaine - therapeutic use | Hypoglycemic Agents - therapeutic use | Metformin - therapeutic use | Humans | Probucol - therapeutic use | Enzyme Inhibitors - therapeutic use | Cholagogues and Choleretics - therapeutic use | Fatty Liver - drug therapy | Pentoxifylline - therapeutic use | Ursodeoxycholic Acid - therapeutic use | Lipotropic Agents - therapeutic use | Antioxidants - therapeutic use | Thiazolidinediones - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Ascorbic Acid - therapeutic use | Vitamin E - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text The antioxidant effect of β-caryophyllene protects rat liver from carbon tetrachloride-induced fibrosis by inhibiting hepatic stellate cell activation
by Calleja, Miguel Angel and Vieites, Jose María and Montero-Meterdez, Trinidad and Torres, María Isabel and Faus, María José and Gil, Angel and Suárez, Antonio
British journal of nutrition, ISSN 0007-1145, 02/2013, Volume 109, Issue 3, pp. 394 - 401
Full Papers | Molecular Nutrition | β-Caryophyllene | Antioxidants | Hepatic stellate cells | Liver fibrosis | Life Sciences & Biomedicine | Nutrition & Dietetics | Science & Technology | Fundamental and applied biological sciences. Psychology | Feeding. Feeding behavior | Biological and medical sciences | Vertebrates: anatomy and physiology, studies on body, several organs or systems | Liver - pathology | Sesquiterpenes - metabolism | Rats, Wistar | Antioxidants - metabolism | Probucol - therapeutic use | Hepatic Stellate Cells - metabolism | Sesquiterpenes - administration & dosage | Carbon Tetrachloride Poisoning - prevention & control | Sesquiterpenes - therapeutic use | Probucol - pharmacology | Carbon Tetrachloride Poisoning - metabolism | Liver - drug effects | Arachidonate 5-Lipoxygenase - chemistry | Lipid Peroxidation - drug effects | Female | Flavoring Agents - therapeutic use | Free Radical Scavengers - therapeutic use | alpha-Tocopherol - metabolism | Hepatic Stellate Cells - drug effects | Cell Line | Cell Survival - drug effects | Arachidonate 5-Lipoxygenase - metabolism | Free Radical Scavengers - metabolism | Liver - metabolism | Hepatic Stellate Cells - enzymology | Free Radical Scavengers - administration & dosage | Lipoxygenase Inhibitors - therapeutic use | Rats | Flavoring Agents - metabolism | Antioxidants - pharmacology | Random Allocation | Flavoring Agents - administration & dosage | Carbon Tetrachloride Poisoning - pathology | Lipoxygenase Inhibitors - administration & dosage | alpha-Tocopherol - therapeutic use | Antioxidants - therapeutic use | Animals | Antioxidants - administration & dosage | Lipoxygenase Inhibitors - metabolism | Oxidative Stress - drug effects | Dietary Supplements | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Pharmacologic Therapy of Non-Alcoholic Steatohepatitis
by Ratziu, Vlad and Zelber-Sagi, Shira
Clinics in liver disease, ISSN 1089-3261, 11/2009, Volume 13, Issue 4, pp. 667 - 688
Sartans | Ursodesoxycholic acid | Fibrosis | Orlistat | Glitazones | Non-alcoholic steatohepatitis | Hepatoprotectants | Steatosis | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Betaine - therapeutic use | Tocopherols - therapeutic use | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Fatty Liver - prevention & control | Probucol - therapeutic use | Clinical Trials as Topic | Anti-Obesity Agents - therapeutic use | Cholagogues and Choleretics - therapeutic use | Fatty Liver - drug therapy | Lactones - therapeutic use | Pentoxifylline - therapeutic use | Ursodeoxycholic Acid - therapeutic use | Lipotropic Agents - therapeutic use | Antioxidants - therapeutic use | Thiazolidinediones - therapeutic use | Free Radical Scavengers - therapeutic use
Journal Article
Details down arrow
4. Full Text Pharmacological inhibition of coronary restenosis: systemic and local approaches
by Guerra, Elena and Byrne, Robert A and Kastrati, Adnan
Expert opinion on pharmacotherapy, ISSN 1465-6566, 10/2014, Volume 15, Issue 15, pp. 2155 - 2171
oral sirolimus | stent | tranilast | restenosis | cilostazol | drug eluting balloon | probucol | Restenosis | Tranilast | Oral sirolimus | Cilostazol | Probucol | Drug eluting balloon | Stent | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Vasodilator Agents - therapeutic use | Humans | ortho-Aminobenzoates - therapeutic use | Probucol - therapeutic use | Drug Delivery Systems | Drug-Eluting Stents - adverse effects | Anti-Bacterial Agents - therapeutic use | Tetrazoles - administration & dosage | Anti-Bacterial Agents - chemistry | Platelet Aggregation Inhibitors - administration & dosage | Tubulin Modulators - administration & dosage | Paclitaxel - administration & dosage | Platelet Aggregation Inhibitors - therapeutic use | Coronary Restenosis - etiology | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | ortho-Aminobenzoates - administration & dosage | Coronary Restenosis - prevention & control | Paclitaxel - therapeutic use | Probucol - administration & dosage | Tubulin Modulators - therapeutic use | Sirolimus - administration & dosage | Antioxidants - therapeutic use | Antioxidants - administration & dosage | Tetrazoles - therapeutic use | Coronary Restenosis - physiopathology | Anti-Bacterial Agents - administration & dosage | Percutaneous Coronary Intervention - adverse effects | Vasodilator Agents - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Pharmacological Interventions for Nonalcoholic Fatty Liver Disease in Adults and in Children: A Systematic Review
by Socha, Piotr and Horvath, Andrea and Vajro, Pietro and Dziechciarz, Piotr and Dhawan, Anil and Szajewska, Hania
Journal of pediatric gastroenterology and nutrition, ISSN 0277-2116, 05/2009, Volume 48, Issue 5, pp. 587 - 596
NASH | NAFLD | Liver disease | Gastroenterology & Hepatology | Pediatrics | Life Sciences & Biomedicine | Nutrition & Dietetics | Science & Technology | Fundamental and applied biological sciences. Psychology | Feeding. Feeding behavior | Gastroenterology. Liver. Pancreas. Abdomen | Vertebrates: anatomy and physiology, studies on body, several organs or systems | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Biological and medical sciences | Medical sciences | Other diseases. Semiology | Hypoglycemic Agents - therapeutic use | Fatty Liver - diet therapy | Liver - pathology | Metformin - therapeutic use | Fatty Liver - pathology | Aspartate Aminotransferases - analysis | Humans | Probucol - therapeutic use | Alanine Transaminase - analysis | Fatty Liver - drug therapy | Randomized Controlled Trials as Topic | Ursodeoxycholic Acid - therapeutic use | Drug Synergism | Thiazolidinediones - therapeutic use | Carnitine - therapeutic use | Vitamin E - therapeutic use | Adult | Acetylcysteine - therapeutic use | Drug Therapy, Combination | Child | Dietary Supplements | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial
by Kim, Bum Joon and Lee, Eun-Jae and Kwon, Sun U and Park, Jong-Ho and Kim, Yong-Jae and Hong, Keun-Sik and Wong, Lawrence K S and Yu, Sungwook and Hwang, Yang-Ha and Lee, Ji Sung and Lee, Juneyoung and Rha, Joung-Ho and Heo, Sung Hyuk and Ahn, Sung Hwan and Seo, Woo-Keun and Park, Jong-Moo and Lee, Ju-Hun and Kwon, Jee-Hyun and Sohn, Sung-Il and Jung, Jin-Man and Navarro, Jose C and Kang, Dong-Wha and Kwon, Sun U and Lee, Juneyoung and Kang, Dong-Wha and Rha, Joung-Ho and Park, Jong-Moo and Lee, Yong-Seok and Lee, Ju-Hun and Kim, Yong-Jae and Hong, Keun-Sik and Yu, Kyung Ho and Sohn, Sung-Il and Ahn, Seong Hwan and Cha, Jae-Kwan and Park, Man-Seok and Kim, Jong S and Yoon, Byung-Woo and Lee, Byung-Chul and Nam, Cheong-Mo and Koo, Ja-Seong and Nam, Hyo-Seok and Park, Kwang-Yeol and Kim, Dae-Hyun and Nah, Hyun-Wook and Cho, Yong-Jin and Kim, Dong-Eog and Han, Moon-Ku and Lee, Kyung-Bok and Heo, Seong Hyuk and Heo, Ji Hoe and Kim, Bum Joon and Cho, Kyung-Hee and Kim, Han-Young and Kim, Young-Dae and Cho, Ah-Hyun and Lee, Kyeong-Yul and Lee, Jin-Soo and Park, Jong-Ho and Seo, Woo-Keun and Kim, Eung-Gyu and Koh, Im-Seok and Choi, Nak-Cheon and Kwon, Jee-Hyun and Lee, June and Hwang, Yang-Ha and Song, Hee-Jeong and Shin, Byung-Soo and Kim, June-Tae and Lee, Soo-Joo and Chung, Pil-Wook and Kim, Seong-Heon and Lee, June-Hong and Shin, Dong-Ik and Do, Jin Kuk and Lee, Sang-Bong and Lee, Young-Bae and Yoo, Bong-Goo and Sung, Sang Min and Jung, Jin-Man and Park, Jeong-Wook and Lee, Tae-Kyung and Navarro, Jose C and San Jos, Maria Cristina Z and Roxas, Artemio and Mallarl-Alvarez, Raquel J and Collantes, Ma. Epifania V and WONG, Lawrence K.S and Fong, Wing-Chi and Tsoi, Tak Hong and Ng, Ping Wing and Lee, Eun-Jae and Lee, Ji Sung and PICASSO investigators and PICASSO Investigators
Lancet neurology, ISSN 1474-4422, 06/2018, Volume 17, Issue 6, pp. 509 - 518
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Cardiovascular Diseases - ethnology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Probucol - therapeutic use | Male | China | Fibrinolytic Agents - therapeutic use | Cerebral Hemorrhage - prevention & control | Female | Aspirin - therapeutic use | Cilostazol - therapeutic use | Republic of Korea | Cerebral Hemorrhage - etiology | Brain Ischemia - complications | Cerebral Hemorrhage - ethnology | Double-Blind Method | Philippines | Treatment Outcome | Stroke - drug therapy | Antioxidants - therapeutic use | Asian Continental Ancestry Group | Stroke - etiology | Stroke - ethnology | Aged | Stroke (Disease) | Prevention | Ischemia | Myocardial infarction | Headache | Cerebral infarction | Aspirin | Stroke | Heart attacks | Diarrhea | Clinical trials | Cardiovascular disease | Lipids | Hemorrhage | Patients | Disease prevention | Motivation | Coronary vessels | Safety | Constipation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Novel cardiovascular drugs in clinical trials
by Biswal, Sasmita
Indian journal of medical sciences, ISSN 0019-5359, 06/2010, Volume 64, Issue 6, pp. 285 - 291
cardiovascular drugs | clinical trials | novel agents | Atherosclerosis | Thiophenes - therapeutic use | Metalloendopeptidases - therapeutic use | Phospholipase A2 Inhibitors - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Probucol - therapeutic use | Lipoxygenase Inhibitors - therapeutic use | Oximes - therapeutic use | Clinical Trials as Topic | Oxazolidinones - therapeutic use | Cardiovascular Agents - therapeutic use | Probucol - analogs & derivatives | Anticholesteremic Agents - therapeutic use | Pyrimidines - therapeutic use | Fibrinolytic Agents - therapeutic use | Benzaldehydes - therapeutic use | Quinolines - therapeutic use | Isoxazoles - therapeutic use | Endothelin Receptor Antagonists | Immunologic Factors - therapeutic use | Clinical trials | Drug therapy | Cardiovascular diseases | Endothelium | Antilipemic agents | Cardiovascular agents | Proteins | Cardiovascular disease | Heart attacks | Muscular system | Cholesterol
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Nanoassembly of Probucol Enables Novel Therapeutic Efficacy in the Suppression of Lung Metastasis of Breast Cancer
by Zhang, Zhiwen and Cao, Haiqiang and Jiang, Shijun and Liu, Zeying and He, Xinyu and Yu, Haijun and Li, Yaping
Small (Weinheim an der Bergstrasse, Germany), ISSN 1613-6810, 11/2014, Volume 10, Issue 22, pp. 4735 - 4745
drug delivery | biomedical applications | nanoassembly | probucol | Drug delivery | Probucol | Biomedical applications | Nanoassembly | Materials Science | Materials Science, Multidisciplinary | Physics, Condensed Matter | Science & Technology - Other Topics | Chemistry, Physical | Physics | Science & Technology | Physics, Applied | Physical Sciences | Chemistry | Nanoscience & Nanotechnology | Technology | Chemistry, Multidisciplinary | Microscopy, Electron, Transmission | Humans | Probucol - therapeutic use | Rats | Breast Neoplasms - drug therapy | Tissue Distribution | Animals | Lung Neoplasms - secondary | Breast Neoplasms - pathology | Female | Mice | Probucol - chemistry | Nanotechnology | Probucol - pharmacokinetics | Drugs | Drug delivery systems | Analysis | Breast cancer | Metastasis | Health aspects | Polyols | Vehicles | Medical research | Index Medicus | Self assembly | Lungs | Breast | In vitro testing | Nanostructure | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Current, New and Future Treatments in Dyslipidaemia and Atherosclerosis
by Chong P.H and Bachenheimer B.S
07/2000, Volume 60, Issue 1, 39
Nicotinic acid, therapeutic use | Hormonal replacements, therapeutic use | Hyperlipidaemia, treatment | Antihyperlipidaemics, therapeutic use | HMG CoA reductase inhibitors, therapeutic use | Diet | Raloxifene, therapeutic use | Vaccines, therapeutic use | Fibric acid derivatives, therapeutic use | Gene therapies, therapeutic use | Probucol, therapeutic use | Atherosclerosis, treatment | Bile acid sequestrants, therapeutic use | Tamoxifen, therapeutic use | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | Medical sciences | General and cellular metabolism. Vitamins | Pharmacology. Drug treatments | Life Style | Arteriosclerosis - drug therapy | Humans | Hyperlipidemias - drug therapy | Arteriosclerosis - physiopathology | Cholesterol - metabolism | Forecasting | Hyperlipidemias - prevention & control | Arteriosclerosis - prevention & control | Anticholesteremic Agents - therapeutic use | Lipoproteins - metabolism | Lipoproteins - drug effects | Hyperlipidemias - physiopathology | Index Medicus
Book Review
Details down arrow
Digital rights down arrow
loading Loading Rights